Caixin

Pharma

Despite bribery scandal, GSK ready to expand in China

Despite its recent, ugly bribery scandal, CEO Andrew Witty says that GlaxoSmithKline has a strong expansion plan in China.

By Meghana Keshavan

New Webinar: The Payer AI Readiness Gap: Why Better Data Will Define the Next Era of Health Plan Performance

We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.

By Verato and MedCity News

The Healthcare Payments Industry Faces a Perception Challenge

Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.

By Lisa Brooks, Vice President, Healthcare Partnerships

Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026

Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.

By Tiffany Cabasso, Operations Director, Kyan Health | Psychologist, FSP